Finance

Lists
DMP:VIE
Dermapharm Holding SE
€39.25
0.00%
(0.00) 1D
Sep 4, 3:30:25 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DMP...
Mkt. cap
1.96B
Avg. vol.
4.00
Volume
0.00
Dividend
2.24%
Quarterly dividend
€0.22
Ex-dividend date
Jun 29, 2026
P/E ratio
14.23
52-wk high
€51.20
52-wk low
€32.05
EPS
€2.76
No. of employees
4K
Mkt. cap
1.96B
Avg. vol.
4.00
Volume
0.00
Dividend
2.24%
Quarterly dividend
€0.22
Ex-dividend date
Jun 29, 2026
P/E ratio
14.23
52-wk high
€51.20
52-wk low
€32.05
EPS
€2.76
No. of employees
4K
Profile
Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations. Wikipedia
About Dermapharm Holding SE
CEOHans-Georg Feldmeier
Employees3.62K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websiteir.dermapharm.de
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
294.90M
296.46M
305.80M
285.15M
Cost of goods sold
101.90M
113.32M
101.39M
92.31M
Cost of revenue
101.90M
113.32M
101.39M
92.31M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
67.31M
81.14M
78.76M
79.38M
Operating expense
132.40M
100.78M
143.59M
147.60M
Total operating expenses
234.30M
214.11M
244.98M
239.92M
Operating income
60.60M
82.35M
60.83M
45.24M
Other non operating income
5.27M
-13.11M
9.84M
25.81M
EBT including unusual items
55.16M
46.16M
61.51M
29.95M
EBT excluding unusual items
55.16M
57.48M
61.51M
59.95M
Income tax expense
14.05M
10.01M
16.38M
6.79M
Effective tax rate
25.47%
21.68%
26.63%
22.68%
Other operating expenses
44.04M
209.00K
44.44M
45.10M
Net income
41.22M
36.89M
45.20M
23.22M
Net profit margin
13.98%
12.44%
14.78%
8.14%
Earnings per share
-
0.73
-
-
Interest and investment income
5.95M
-
1.42M
2.01M
Interest expense
-16.68M
-11.02M
-10.68M
-12.29M
Net interest expenses
-10.73M
-11.02M
-9.26M
-10.28M
Depreciation and amortization charges
21.05M
19.43M
20.39M
23.12M
EBITDA
81.51M
89.38M
81.14M
97.45M
Gain or loss from assets sale
19.00K
63.00K
90.00K
31.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps